title: Central Nervous System Pseudoprogression in a Patient Treated with PD-1 Checkpoint Inhibitor.
authors.affiliation: *Department of Medical Oncology and Haematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada; and †Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Mark K
authors.initials: MK
authors.lastname: Doherty
authors.forename: Kevin
authors.initials: K
authors.lastname: Jao
authors.forename: Frances A
authors.initials: FA
authors.lastname: Shepherd
authors.forename: Lili-Naz
authors.initials: LN
authors.lastname: Hazrati
authors.forename: Natasha B
authors.initials: NB
authors.lastname: Leighl
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy* / Q000473:pathology*; D000077192:Adenocarcinoma of Lung; D018450:Disease Progression; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D008297:Male; D008875:Middle Aged; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors* / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D061026:Programmed Cell Death 1 Receptor